Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?news2022-12-16T10:00:26+00:00December 16th, 2022|The New York Times|
Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trialnews2022-12-02T21:55:07+00:00December 2nd, 2022|The New York Times|
Alzheimer’s Drug May Benefit Some Patients, New Data Showsnews2022-11-30T00:50:06+00:00November 30th, 2022|The New York Times|
The End of Covid Vaccines at ‘Warp Speed’news2022-11-18T14:02:03+00:00November 18th, 2022|The New York Times|
Gene Treatment for Rare Epilepsy Causes Brain Side Effect in 2 Childrennews2022-10-26T18:19:16+00:00October 26th, 2022|The New York Times|
Some Breast Cancer Patients Could Skip Surgery, Study Suggestsnews2022-10-25T23:47:44+00:00October 25th, 2022|The New York Times|
¿Las nuevas vacunas contra la malaria podrán erradicarla?news2022-10-08T09:00:27+00:00October 8th, 2022|The New York Times|
Can New Vaccines Finally Eradicate Malaria?news2022-10-04T10:12:35+00:00October 4th, 2022|The New York Times|
Price of New A.L.S. Treatment Will Be $158,000 Per Year, Maker Saysnews2022-09-30T20:16:18+00:00September 30th, 2022|The New York Times|
Un nuevo tratamiento contra el VIH ha probado ser un éxito. ¿Será accesible en África?news2022-09-30T09:00:20+00:00September 30th, 2022|The New York Times|
